THYMIC CARCINOMA
Clinical trials for THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug combo shows promise for rare chest tumors
Disease control OngoingThis study tested whether adding the targeted drug cetuximab to standard chemotherapy before surgery could improve outcomes for people with advanced thymoma or thymic carcinoma. The trial enrolled 18 adults with stage II to IVA disease. Researchers measured how many tumors comple…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New drug combo shows promise for rare thymic cancer
Disease control OngoingThis study tested a combination of two drugs, pembrolizumab and sunitinib, in 9 people with advanced thymic carcinoma that had spread or couldn't be removed and had stopped responding to standard chemotherapy. The goal was to see if the combination could shrink tumors. The approa…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 17, 2026 01:50 UTC
-
Immunotherapy shows promise for rare chest cancers
Disease control OngoingThis study tests the drug nivolumab in 55 people with advanced thymoma or thymic carcinoma that has worsened after initial chemotherapy. The goal is to see if nivolumab can slow cancer growth and how safe it is. Participants receive nivolumab infusions, and researchers track tumo…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 17, 2026 01:49 UTC
-
New hope for rare thymus cancers: immune drug shows promise
Disease control OngoingThis study tests a drug called avelumab in people with thymoma or thymic carcinoma that returned after platinum chemotherapy. Avelumab helps the immune system fight cancer. The goal is to see if it is safe and can shrink or slow tumor growth. About 56 adults will receive the drug…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Scientists hunt for cancer clues in blood and tissue
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood, tumor tissue, and other body fluids from 1,000 adults with lung cancer, thymus cancer, or mesothelioma. Researchers analyze these samples to find biological markers that could predict how cancer will behave or respond to treatments. The goal is to impro…
Matched conditions: THYMIC CARCINOMA
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:15 UTC